198 related articles for article (PubMed ID: 15299241)
21. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
Chansanroj K; Betz G
Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
[TBL] [Abstract][Full Text] [Related]
22. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
Ozeki Y; Ando M; Watanabe Y; Danjo K
J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
[TBL] [Abstract][Full Text] [Related]
24. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
Orlu M; Cevher E; Araman A
Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
[TBL] [Abstract][Full Text] [Related]
25. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
26. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
[TBL] [Abstract][Full Text] [Related]
27. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
Zeng A; Yuan B; Fu Q; Wang C; Zhao G
Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
[TBL] [Abstract][Full Text] [Related]
28. A novel system for three-pulse drug release based on "tablets in capsule" device.
Li B; Zhu J; Zheng C; Gong W
Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
[TBL] [Abstract][Full Text] [Related]
29. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
[TBL] [Abstract][Full Text] [Related]
30. Release from or through a wax matrix system. III. Basic properties of release through the wax matrix layer.
Yonezawa Y; Ishida S; Suzuki S; Sunada H
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):814-7. PubMed ID: 12045337
[TBL] [Abstract][Full Text] [Related]
31. Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding.
Vaz CM; van Doeveren PF; Dias GR; Reis RL; Cunha AM
Macromol Biosci; 2004 Aug; 4(8):795-801. PubMed ID: 15468273
[TBL] [Abstract][Full Text] [Related]
32. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
33. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery.
Wang Y; Chang HI; Wertheim DF; Jones AS; Jackson C; Coombes AG
Biomaterials; 2007 Nov; 28(31):4619-27. PubMed ID: 17659772
[TBL] [Abstract][Full Text] [Related]
35. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.
Nunthanid J; Huanbutta K; Luangtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 Feb; 68(2):253-9. PubMed ID: 17616377
[TBL] [Abstract][Full Text] [Related]
36. [Preparation of nifidipine pulsatile release tablets].
Zhang Y; Zhang ZR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):261-3. PubMed ID: 15071935
[TBL] [Abstract][Full Text] [Related]
37. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
Odeku OA; Fell JT
J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
[TBL] [Abstract][Full Text] [Related]
39. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Kumar RV; Sinha VR
Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
[TBL] [Abstract][Full Text] [Related]
40. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
Dvorácková K; Rabisková M; Masteiková R; Vocilková L
Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
